Behavioral Health Psychotropics

Printing and PDF export are disabled for this protected preview. Continue reading inside the DiraChart reader.

Trace DC53-1

DiraChart Clinical Reference
Protected section 1 of 15
← Document menu
Nursing Home · DiraChart

1. Purpose and clinical relevance

DiraChart Clinical Reference

Section NavigationPart 1 of 15PreviousNext

General Section

DIRACHART — SKILLED DOCUMENTATION · NURSING HOMES (DGEX-SNF)

DiraChart Clinical Reference · Read-only reference edition

Clinical Reference · 2.5

Behavioral Health, Psychotropics & Gradual Dose Reduction

Non-pharmacologic behavioral interventions first; when a psychotropic is used, the documented indication and target symptoms, the monitoring, the PRN time limits, the gradual-dose-reduction schedule, and the antipsychotic-in-dementia caution — the record surveyed under F740–F745 and F758.

Module code

SNF-BEHAVIORAL

Version

1.0 · Population: Adult · DiraChart reference edition

Used alongside

Cognitive/Mental Status · Psychiatric · Pain · Restraints · Skilled-Daily · Dementia overlay

MDS section(s)

C (BIMS) · D (PHQ mood) · E (behavior) · N (psychotropic medications — antipsychotic, antianxiety, antidepressant, hypnotic, anticonvulsant, opioid)

Survey F-tag(s)

F740–F745 (behavioral health services) · F758 (psychotropic / unnecessary drugs — PRN limits, GDR, indications) · F604/F605 (restraints)

How to use this module

Fill every model note and smart phrase with the shift’s actual values and the resident’s current orders — these are structured examples to edit, never phrases to copy. The universal writing rules in Foundations (the necessity sentence, quantified outcomes, teach-back, closed-loop coordination, MDS-supportive documentation, and care-plan linkage) apply throughout and are not reprinted here. Disease-specific days route to the overlays. Verify each threshold and citation against the current source before use.

Section NavigationPart 1 of 15PreviousNext